The (NIBRT) expansion enabled increased capacity and capability to conduct manufacturing-focused research and training in advanced therapeutics such as cell therapies, gene therapies, mRNA and other novel vaccines. This build incorporates 1,800 m2 of new space, including five research laboratories and state of the art training suites, into the existing NIBRT facility that will be dedicated to advanced therapeutics.

Project Details

Client: J. Sisk & Sons Limited

Products Used: Monarflex RMB400 1000m2

Sector: Pharma & Life Sciences